Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2002 Mar;40(1):1-7.
doi: 10.3347/kjp.2002.40.1.1.

Management of malaria in Thailand

Udomsak Silachamroon  1 , Srivicha Krudsood, Nanthaphorn Phophak, Sornchai Looareesuwan
Affiliations
Review

Management of malaria in Thailand

Udomsak Silachamroon et al. Korean J Parasitol. 2002 Mar.

Abstract

The purpose of treatment for uncomplicated malaria is to produce a radical cure using the combination of: artesunate (4 mg/kg/day) plus mefloquine (8 mg/kg day) for 3 days: a fixed dose of artemether and lumefantrine (20/120 mg tablet) named Coartem (4 tablets twice a day for three days for adults weighing more than 35 kg): quinine 10 mg/kg 8-hourly plus tetracycline 250 mg 6-hourly for 7 days (or doxycycline 200 mg as an alternative to tetracycline once a day for 7 days) in patients aged 8 years and over: Malarone (in adult 4 tablets daily for 3 days). In treating severe malaria, early diagnosis and treatment with a potent antimalarial drug is recommended to save the patient's life. The antimalarial drugs of choice are: intravenous quinine or a parenteral form of an artemisinin derivative (artesunate i.v./i.m. for 2.4 mg/kg followed by 1.2 mg/kg injection at 12 and 24 hr and then daily for 5 dayss; artemether i.m. 3.2 mg/kg injection followed by 1.6 mg/kg at 12 and 24 hrs and then daily for 5 days; artemether i.m. (Artemotil) with the same dose of artemether or artesunate suppository (5 mg/kg) given rectally 12 hourly for 3 days. Oral artemisinin derivatives (artesunate, artemether, and dihydroartemisinin with 4 mg/kg/day) could replace parenteral forms when patients can tolerate oral medication. Oral mefloquine (25 mg/kg divided into two doses 8 hrs apart) should be given at the end of the artemisinin treatment course to reduce recrudescence.

PubMed Disclaimer

Similar articles

See all similar articles

References

    1. Bunnag D, Karbwan J, Harinasuta T. Artemether in the treatment of multiple drug resistant falciparum malaria. Southeast Asian J Trop Med Public Health. 1992;23:762–768. - PubMed
    1. Looareesuwan S, Harinasuta T, Chongsuphajaisiddhi T. Drug resistant malaria with special reference to Thailand. Southeast Asian J Trop Med Public Health. 1992b;23:621–634. - PubMed
    1. Looareesuwan S, Kyle DE, Viravan C, Vanijanonta S, Wilairatana P, Wernsdorfer WH. Clinical study of pyronaridine for the treatment of acute uncomplicated falciparum malaria in Thailand. Am J Trop Med Hyg. 1996b;54:205–209. - PubMed
    1. Looareesuwan S, Olliaro P, White NJ, et al. Consensus recommendation on the treatment of malaria in Southeast Asia. Southeast Asian J Trop Med Public Health. 1998a;29:355–360. - PubMed
    1. Looareesuwan S, Schilizzi BM, Oosterhuis B, et al. Dose-fining and efficacy study for i.m. artemotil (beta-arteether) and comparison with i.m. artemether in acute uncomplicated P. falciparum malaria. Brit J Clin Pharm. 2002 (in press) - PMC - PubMed